These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20042655)

  • 1. Regulation of VEGF-A in uveal melanoma.
    el Filali M; Missotten GS; Maat W; Ly LV; Luyten GP; van der Velden PA; Jager MJ
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2329-37. PubMed ID: 20042655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
    Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A
    Oncotarget; 2016 Feb; 7(7):7816-28. PubMed ID: 26761211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine impact of VEGF-A on uveal melanoma cells.
    Koch KR; Refaian N; Hos D; Schlereth SL; Bosch JJ; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2697-704. PubMed ID: 24677103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic profile of uveal melanoma.
    Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
    Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
    Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
    Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab and intraocular tumors: an intriguing paradox.
    el Filali M; Ly LV; Luyten GP; Versluis M; Grossniklaus HE; van der Velden PA; Jager MJ
    Mol Vis; 2012; 18():2454-67. PubMed ID: 23077404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
    Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
    Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
    Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanoma.
    Bronkhorst IH; Jehs TM; Dijkgraaf EM; Luyten GP; van der Velden PA; van der Burg SH; Jager MJ
    JAMA Ophthalmol; 2014 May; 132(5):614-21. PubMed ID: 24626595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
    Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
    Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
    Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
    Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells.
    Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
    Biochem Pharmacol; 2006 Jun; 72(1):19-31. PubMed ID: 16682012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.
    Tsuzuki T; Okada H; Cho H; Tsuji S; Nishigaki A; Yasuda K; Kanzaki H
    Hum Reprod; 2012 Feb; 27(2):523-30. PubMed ID: 22128293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
    Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient inhibition of uveal melanoma via ternary siRNA complexes.
    Xie L; Yang Y; Shen J
    Int J Pharm; 2020 Jan; 573():118894. PubMed ID: 31765784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.